Gadoteridol is a macrocyclic nonionic gadolinium-based compound used as a contrast agent for magnetic resonance imaging (MRI). It enhances the visibility of lesions with abnormal vascularity or blood-brain barrier disruption in the brain, spine, and surrounding tissues.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing ProHance?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Calteridol calcium
pharmaceutical raw material
Gadoteric acid
pharmaceutical raw material
Gadodiamide hydrate
pharmaceutical raw material
Gadobutrol
pharmaceutical raw material
Gadopentetate dimeglumine
pharmaceutical raw material
Manidipine
pharmaceutical raw material
Ixazomib citrate 1,3,2-dioxaborinane
pharmaceutical raw material
Tofogliflozin hydrate
pharmaceutical raw material
The international HS code for ProHance (CAS 120066-54-8) is 2846.90.
2846.90
2846 90 60
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
DPNNNPAKRZOSMO-UHFFFAOYSA-K
CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
Sourcing ProHance?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.